NCT05650606

Brief Summary

Stroke is a major cause of disability, with 2-3% of Americans reporting stroke related impairments (Tsao 2022). Following stroke, over half of Medicare patients are discharged to post-acute care facilities or receive home-based health care (Tsao 2022). Inpatient rehabilitation guidelines are lacking, with many interventions based on research of patients with chronic stroke. There is great need for randomized clinical trials during the early subacute period (Bernhardt 2017, Jordan 2021). Clinical practice guidelines recommend high intensity gait training (HIGT) for ambulatory patients with chronic stroke (Hornby 2020). Outpatient HIGT protocols incorporating variable stepping demonstrate equivalent effectiveness to forward stepping protocols (Hornby 2019) and have yielded superior results to lower intensity therapies (Hornby 2019, Hornby 2016). Research suggests that HIGT with variable stepping is feasible during inpatient rehabilitation (Hornby 2015, Moore 2020). Pre-post studies suggest that participation in HIGT during inpatient rehabilitation yields greater improvements in walking without an increase in adverse events. (Moore 2020). Despite this, there are no randomized controlled trials evaluating HIGT in the inpatient setting. The subacute phase of stroke recovery may be a critical time for neuroplasticity (Dromerick 2021). Not only might rehabilitation interventions be more effective when initiated earlier (Biernaskie 2004, Dromerick 2021) but because inpatient rehabilitation represents the transition from hospital to home, interventions during this timeframe have the potential to improve discharge disposition, enhance quality of life, and reduce utilization of post-discharge services. In this randomized controlled study, investigators will determine how participation in HIGT during inpatient rehabilitation affects balance, ambulation, and quality of life after 14 and/or 21 days of inpatient rehabilitation, and 8 weeks post-discharge. Investigators will also determine if HIGT reduces health care burden with a cost-effectiveness analysis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 14, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

March 18, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2023

Completed
Last Updated

October 13, 2023

Status Verified

October 1, 2023

Enrollment Period

7 months

First QC Date

December 6, 2022

Last Update Submit

October 11, 2023

Conditions

Keywords

High Intensity Gait TrainingInpatient RehabilitationHealth Care Burden

Outcome Measures

Primary Outcomes (12)

  • 10 Meter Walk Test at Self Selected Speed

    Used to assess walking speed over a short distance at the patient's chosen speed.

    (Day 13-15) - (Day 1-3)

  • 10 Meter Walk Test at Self Selected Speed

    Used to assess walking speed over a short distance at the patient's chosen speed.

    (Day 20-22)- (Day 1-3)

  • 10 Meter Walk Test at Self Selected Speed

    Used to assess walking speed over a short distance at the patient's chosen speed.

    (Day 62 to Day 86)-(Day 14 to Day 21)

  • 10 Meter Walk Test at Fast Speed

    Used to assess walking speed over a short distance at the patient's self determined speed that is as fast as they can safely walk..

    (Day 13-15) - (Day 1-3)

  • 10 Meter Walk Test at Fast Speed

    Used to assess walking speed over a short distance at the patient's self determined speed that is as fast as they can safely walk..

    (Day 20-22) - (Day 1-3)

  • 10 Meter Walk Test at Fast Speed

    Used to assess walking speed over a short distance at the patient's self determined speed that is as fast as they can safely walk..

    (Day 62 to Day 86)-(Day 14 to Day 21)

  • 6 Minute Walk Test

    Used to assess walking endurance and aerobic capacity. The total distance the patient walks over six minutes is recorded.

    (Day 13-15) - (Day 1-3)

  • 6 Minute Walk Test

    Used to assess walking endurance and aerobic capacity. The total distance the patient walks over six minutes is recorded.

    (Day 20-22) - (Day 1-3)

  • 6 Minute Walk Test

    Used to assess walking endurance and aerobic capacity. The total distance the patient walks over six minutes is recorded.

    (Day 62 to Day 86)-(Day 14 to Day 21)

  • Stroke Impact Scale (SIS)

    The Stroke Impact Scale (SIS) is a self report questionnaire that uses 9 categories to assess disability and quality of life after having had a stroke.

    (Day 62 to Day 86)-(Day 14 to Day 21)

  • Life Space Assessment (LSA)

    The LSA is a self report tool that measures frequency of independent mobility using 9 questions.

    (Day 62 to Day 86)-(Day 14 to Day 21)

  • Cost of inpatient rehabilitation and post-discharge health care services

    This will include the cost of home health care, outpatient therapies, subacute nursing facility and hospital readmissions

    (Day 62 to Day 86) - (Day 1 to Day 3)

Secondary Outcomes (12)

  • BERG Balance Scale

    (Day 13-15) - (Day 1-3)

  • BERG Balance Scale

    (Day 20-22) - (Day 1-3)

  • BERG Balance Scale

    (Day 62 to Day 86)-(Day 14 to Day 21)

  • 5 Times Sit to Stand

    (Day 13-15) - (Day 1-3)

  • 5 Times Sit to Stand

    (Day 20-22) - (Day 1-3)

  • +7 more secondary outcomes

Study Arms (2)

High Intensity Gait Training

EXPERIMENTAL

HIGT will be performed 4-6 times per week in place of conventional physical therapy. The patient's heart rate(HR)and blood pressure(BP) will be measured throughout each session. If the HR or BP is out of the acceptable range, patients will undergo standard physical therapy for that session, and the medical team will be contacted. Target HR zones will be calculated with the Karvonen formula. The first session goal is to reach a target HR range that is 50-60% of heart rate reserve. The goal for subsequent sessions is to reach 70-80% of heart rate reserve. Rate of perceived exertion (RPE) will also be utilized. The primary therapist will design an individualized HIGT treatment program with a combination of speed dependent treadmill activities, activity-based treadmill activities, stair training, and over ground activities. The patient will be reminded during each session to ask for a rest as needed. Standing rests are preferred over sitting rests, but either may be utilized.

Other: High Intensity Gait Training

Conventional

ACTIVE COMPARATOR

The conventional physical therapy sessions are what a patient would normally receive during their rehabilitation. Physical therapy sessions are usually 60-90 minutes per day for 5 days each week, and possibly one 30-minute session on a 6th day. Physical therapy sessions are focused on gait, balance, and strengthening activities to address goals related to functional mobility. Clinicians administering therapy to patients in this arm will not be given instructions on the types of therapies they administer; however, they will not be permitted to do HIGT with patients. Therapists will be permitted to use other devices such as Ekso exoskeleton, Lite Gait, Rifton Tram Body Weight Support Devices, and Electrical Stimulation devices including the XCITE and RT300.

Other: Conventional Therapy

Interventions

Physical therapy intervention for improving gait in patients post Cerebral Vascular Accident.

High Intensity Gait Training

Standard inpatient rehabilitation physical therapy treatments for Cerebral Vascular Accident.

Conventional

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults (≥18 years) recovering from a unilateral cerebral infarct with resultant hemiparesis occurring less than three months prior. Patients must have an expected length of stay of at least 14 days.

You may not qualify if:

  • are older than 85 years of age have evidence of intracranial hemorrhage on head imaging
  • have had a brainstem, cerebellar or bilateral hemisphere stroke
  • are medically unstable
  • are pregnant
  • have chronic cardiorespiratory disease
  • on oxygen
  • angina
  • unstable arrhythmias
  • ischemic cardiomyopathy (Ejection Fraction \<50%)
  • unable to follow 2 steps commands accurately
  • neurological comorbidities that affect gait
  • Parkinson's
  • severe polyneuropathy
  • unable to walk at least 150 feet premorbid
  • dependent assistance level for transfer from a chair to a bed as assessed by physical therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunnyview Rehabilitation Hospital

Schenectady, New York, 12308, United States

Location

Related Publications (10)

  • Bernhardt J, Hayward KS, Kwakkel G, Ward NS, Wolf SL, Borschmann K, Krakauer JW, Boyd LA, Carmichael ST, Corbett D, Cramer SC. Agreed Definitions and a Shared Vision for New Standards in Stroke Recovery Research: The Stroke Recovery and Rehabilitation Roundtable Taskforce. Neurorehabil Neural Repair. 2017 Sep;31(9):793-799. doi: 10.1177/1545968317732668.

    PMID: 28934920BACKGROUND
  • Biernaskie J, Chernenko G, Corbett D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci. 2004 Feb 4;24(5):1245-54. doi: 10.1523/JNEUROSCI.3834-03.2004.

    PMID: 14762143BACKGROUND
  • Dromerick AW, Geed S, Barth J, Brady K, Giannetti ML, Mitchell A, Edwardson MA, Tan MT, Zhou Y, Newport EL, Edwards DF. Critical Period After Stroke Study (CPASS): A phase II clinical trial testing an optimal time for motor recovery after stroke in humans. Proc Natl Acad Sci U S A. 2021 Sep 28;118(39):e2026676118. doi: 10.1073/pnas.2026676118.

    PMID: 34544853BACKGROUND
  • Hornby TG, Holleran CL, Leddy AL, Hennessy P, Leech KA, Connolly M, Moore JL, Straube D, Lovell L, Roth E. Feasibility of Focused Stepping Practice During Inpatient Rehabilitation Poststroke and Potential Contributions to Mobility Outcomes. Neurorehabil Neural Repair. 2015 Nov-Dec;29(10):923-32. doi: 10.1177/1545968315572390. Epub 2015 Feb 26.

    PMID: 25721233BACKGROUND
  • Hornby TG, Holleran CL, Hennessy PW, Leddy AL, Connolly M, Camardo J, Woodward J, Mahtani G, Lovell L, Roth EJ. Variable Intensive Early Walking Poststroke (VIEWS): A Randomized Controlled Trial. Neurorehabil Neural Repair. 2016 Jun;30(5):440-50. doi: 10.1177/1545968315604396. Epub 2015 Sep 3.

    PMID: 26338433BACKGROUND
  • Hornby TG, Henderson CE, Plawecki A, Lucas E, Lotter J, Holthus M, Brazg G, Fahey M, Woodward J, Ardestani M, Roth EJ. Contributions of Stepping Intensity and Variability to Mobility in Individuals Poststroke. Stroke. 2019 Sep;50(9):2492-2499. doi: 10.1161/STROKEAHA.119.026254. Epub 2019 Aug 22.

    PMID: 31434543BACKGROUND
  • Hornby TG, Reisman DS, Ward IG, Scheets PL, Miller A, Haddad D, Fox EJ, Fritz NE, Hawkins K, Henderson CE, Hendron KL, Holleran CL, Lynskey JE, Walter A; and the Locomotor CPG Appraisal Team. Clinical Practice Guideline to Improve Locomotor Function Following Chronic Stroke, Incomplete Spinal Cord Injury, and Brain Injury. J Neurol Phys Ther. 2020 Jan;44(1):49-100. doi: 10.1097/NPT.0000000000000303.

    PMID: 31834165BACKGROUND
  • Jordan N, Deutsch A. (2021). Why and How to Demonstrate the Value of Rehabilitation Services. ACRM, 000:1-6. https://doi.org/10.1016/j.apmr.2021.06.028

    BACKGROUND
  • Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.

    PMID: 35078371BACKGROUND
  • Moore JL, Nordvik JE, Erichsen A, Rosseland I, Bo E, Hornby TG; FIRST-Oslo Team. Implementation of High-Intensity Stepping Training During Inpatient Stroke Rehabilitation Improves Functional Outcomes. Stroke. 2020 Feb;51(2):563-570. doi: 10.1161/STROKEAHA.119.027450. Epub 2019 Dec 30.

    PMID: 31884902BACKGROUND

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Patricia Broschart Valenza, DPT

    Sunnyview Rehabilitation Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Therapy Supervisor

Study Record Dates

First Submitted

December 6, 2022

First Posted

December 14, 2022

Study Start

March 18, 2023

Primary Completion

October 11, 2023

Study Completion

October 11, 2023

Last Updated

October 13, 2023

Record last verified: 2023-10

Locations